Search results
The page "Discussion:Ceritinib" does not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search result below to see whether the topic is already covered.
and targeting a broader set of resistance mutations. As such, Novartis' ceritinib was approved by the FDA in April 2014 for treatment of NSCLC. It provided...17 KB (1,959 words) - 19:53, 29 May 2025